Cadherin signaling: Keeping cells in touch

F1000Research

Volumn 4, Issue , 2015, Pages

  Klezovitch, Olga ^a   Vasioukhin, Valeri ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CADHERIN; CATENIN; GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; PROTEIN HIPPO; PROTEIN P120; UNCLASSIFIED DRUG;

ACTIN FILAMENT; CELL ADHESION; CELL BODY; CELL COMMUNICATION; CELL JUNCTION; CELL NUCLEUS; CELL PROLIFERATION; CELL ULTRASTRUCTURE; COMPLEX FORMATION; CONTACT INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN FAMILY; REVIEW; TRANSCRIPTION REGULATION;

EID: 84940998464     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.6445.1     Document Type: Review

References (79)

1. Stepniak E Radice GL Vasioukhin V: Adhesive and signaling functions of cadherins and catenins in vertebrate development. Cold Spring Harb Perspect Biol. 2009;1(5):a002949. 20066120 10.1101/cshperspect.a002949 2773643
2. Capaldo CT Farkas AE Nusrat A: Epithelial adhesive junctions. F1000Prime Rep. 2014;6:1. 24592313 10.12703/P6-1 3883420
3. Maître J Heisenberg CP: Three functions of cadherins in cell adhesion. Curr Biol. 2013;23(14):R626-33. 23885883 10.1016/j.cub.2013.06.019 3722483 F1000 Recommendation
4. Takeichi M: Dynamic contacts: rearranging adherens junctions to drive epithelial remodelling. Nat Rev Mol Cell Biol. 2014;15(6):397-410. 24824068 10.1038/nrm3802
5. Priya R Yap AS: Active tension: the role of cadherin adhesion and signaling in generating junctional contractility. Curr Top Dev Biol. 2015;112:65-102. 25733138 10.1016/bs.ctdb.2014.11.016
6. Röper K: Integration of cell-cell adhesion and contractile actomyosin activity during morphogenesis. Curr Top Dev Biol. 2015;112:103-27. 25733139 10.1016/bs.ctdb.2014.11.017
7. McClatchey AI Yap AS: Contact inhibition (of proliferation) redux. Curr Opin Cell Biol. 2012;24(5):685-94. 22835462 10.1016/j.ceb.2012.06.009
8. Eagle H Levine EM: Growth regulatory effects of cellular interaction. Nature. 1967;213(5081):1102-6. 6029791 10.1038/2131102a0
9. St Croix B Sheehan C Rak JW: E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27 KIP1. J Cell Biol. 1998;142(2):557-71. 9679152 10.1083/jcb.142.2.557 2133056
10. Watabe M Nagafuchi A Tsukita S: Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol. 1994;127(1):247-56. 7929567 10.1083/jcb.127.1.247 2120192
11. Perl AK Wilgenbus P Dahl U: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998;392(6672):190-3. 9515965 10.1038/32433
12. Perrais M Chen X Perez-Moreno M: E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell. 2007;18(6):2013-25. 17392517 10.1091/mbc.E06-04-0348 1877107 F1000 Recommendation
13. Hoschuetzky H Aberle H Kemler R: Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol. 1994;127(5):1375-80. 7962096 10.1083/jcb.127.5.1375 2120252
14. Qian X Karpova T Sheppard AM: E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 2004;23(8):1739-48. 15057284 10.1038/sj.emboj.7600136 394229 F1000 Recommendation
15. Cole BK Curto M Chan AW: Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing. Mol Cell Biol. 2008;28(4):1274-84. 18086884 10.1128/MCB.01139-07 2258752 F1000 Recommendation
16. Curto M Cole BK Lallemand D: Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol. 2007;177(5):893-903. 17548515 10.1083/jcb.200703010 2064288 F1000 Recommendation
17. Benhamouche S Curto M Saotome I: Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev. 2010;24(16):1718-30. 20675406 10.1101/gad.1938710 2922501 F1000 Recommendation
18. Grazia Lampugnani M Zanetti A Corada M: Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol. 2003;161(4):793-804. 12771128 10.1083/jcb.200209019 2199373 F1000 Recommendation
19. Lampugnani MG Orsenigo F Gagliani MC: Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol. 2006;174(4):593-604. 16893970 10.1083/jcb.200602080 2064264 F1000 Recommendation
20. Suyama K Shapiro I Guttman M: A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer cell. 2002;2(4):301-14. 12398894 10.1016/S1535-6108(02)00150-2 F1000 Recommendation
21. Pece S Chiariello M Murga C: Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem. 1999;274(27):19347-51. 10383446 10.1074/jbc.274.27.19347
22. Carmeliet P Lampugnani MG Moons L: Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 1999;98(2):147-57. 10428027 10.1016/S0092-8674(00)81010-7 F1000 Recommendation
23. Rudini N Felici A Giampietro C: VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J. 2008;27(7):993-1004. 18337748 10.1038/emboj.2008.46 2323269 F1000 Recommendation
24. Clevers H Nusse R: Wnt/β-catenin signaling and disease. Cell. 2012;149(6):1192-205. 22682243 10.1016/j.cell.2012.05.012
25. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469-80. 17081971 10.1016/j.cell.2006.10.018
26. Heuberger J Birchmeier W: Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2(2):a002915. 20182623 10.1101/cshperspect.a002915 2828280
27. McCrea PD Maher MT Gottardi CJ: Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol. 2015;112:129-96. 25733140 10.1016/bs.ctdb.2014.11.018 4410048
28. Schackmann RC Tenhagen M van de Ven RA: p120-catenin in cancer - mechanisms, models and opportunities for intervention. J Cell Sci. 2013;126(Pt 16):3515-25. 23950111 10.1242/jcs.134411
29. Daniel JM Reynolds AB: The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol. 1999;19(5):3614-23. 10207085 84161
30. Park JI Kim SW Lyons JP: Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell. 2005;8(6):843-54. 15935774 10.1016/j.devcel.2005.04.010 F1000 Recommendation
31. Spring CM Kelly KF O'Kelly I: The catenin p120 ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp Cell Res. 2005;305(2):253-65. 15817151 10.1016/j.yexcr.2005.01.007
32. Perez-Moreno M Davis MA Wong E: p120-catenin mediates inflammatory responses in the skin. Cell. 2006;124(3):631-44. 16469707 10.1016/j.cell.2005.11.043 2443688 F1000 Recommendation
33. Stairs DB Bayne LJ Rhoades B: Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer cell. 2011;19(4):470-83. 21481789 10.1016/j.ccr.2011.02.007 3077713 F1000 Recommendation
34. Buckley CD Tan J Anderson KL: Cell adhesion. The minimal cadherin-catenin complex binds to actin filaments under force. Science. 2014;346(6209):1254211. 25359979 10.1126/science.1254211 4364042 F1000 Recommendation
35. Vasioukhin V Bauer C Degenstein L: Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell. 2001;104(4):605-17. 11239416 10.1016/S0092-8674(01)00246-X F1000 Recommendation
36. Nemade RV Bierie B Nozawa M: Biogenesis and function of mouse mammary epithelium depends on the presence of functional alpha-catenin. Mech Dev. 2004;121(1):91-9. 14706703 10.1016/j.mod.2003.09.007 2405923
37. Kostetskii I Li J Xiong Y: Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res. 2005;96(3):346-54. 15662031 10.1161/01.RES.0000156274.72390.2c
38. Li J Gao E Vite A: Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity. Circ Res. 2015;116(1):70-9. 25305307 10.1161/CIRCRESAHA.116.304472 4282606
39. Kobielak A Fuchs E: Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A. 2006;103(7):2322-7. 16452166 10.1073/pnas.0510422103 1413714
40. Silvis MR Kreger BT Lien WH: α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal. 2011;4(174):ra33. 21610251 10.1126/scisignal.2001823 3366274
41. Piao H Yuan Y Wang M: α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling. Nat Cell Biol. 2014;16(3):245-54. 24509793 10.1038/ncb2909 3943677 F1000 Recommendation
42. Lien W Gelfand VI Vasioukhin V: Alpha-E-catenin binds to dynamitin and regulates dynactin-mediated intracellular traffic. J Cell Biol. 2008;183(6):989-97. 19075109 10.1083/jcb.200805041 2600751 F1000 Recommendation
43. Choi SH Estarás C Moresco JJ: α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes. Genes Dev. 2013;27(22):2473-88. 24240237 10.1101/gad.229062.113 3841736 F1000 Recommendation
44. Lien WH Klezovitch O Fernandez TE: alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. Science. 2006;311(5767):1609-12. 16543460 10.1126/science.1121449 2556178 F1000 Recommendation
45. Schlegelmilch K Mohseni M Kirak O: Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell. 2011;144(5):782-95. 21376238 10.1016/j.cell.2011.02.031 3237196 F1000 Recommendation
46. Kim NG Koh E Chen X: E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci U S A. 2011;108(29):11930-5. 21730131 10.1073/pnas.1103345108 3141988 F1000 Recommendation
47. Azzolin L Panciera T Soligo S: YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158(1):157-70. 24976009 10.1016/j.cell.2014.06.013 F1000 Recommendation
48. Barry ER Camargo FD: The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol. 2013;25(2):247-53. 23312716 10.1016/j.ceb.2012.12.006
49. Yu FX Guan KL: The Hippo pathway: regulators and regulations. Genes Dev. 2013;27(4):355-71. 23431053 10.1101/gad.210773.112 3589553
50. Leung CY Zernicka-Goetz M: Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms. Nat Commun. 2013;4:2251. 23903990 10.1038/ncomms3251 3741640
51. Dupont S Morsut L Aragona M: Role of YAP/TAZ in mechanotransduction. Nature. 2011;474(7350):179-83. 21654799 10.1038/nature10137 F1000 Recommendation
52. Gaspar P Tapon N: Sensing the local environment: actin architecture and Hippo signalling. Curr Opin Cell Biol. 2014;31:74-83. 25259681 10.1016/j.ceb.2014.09.003
53. Aragona M Panciera T Manfrin A: A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013;154(5):1047-59. 23954413 10.1016/j.cell.2013.07.042 F1000 Recommendation
54. Yu F Zhao B Panupinthu N: Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150(4):780-91. 22863277 10.1016/j.cell.2012.06.037 3433174 F1000 Recommendation
55. Zhao B Wei X Li W: Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747-61. 17974916 10.1101/gad.1602907 2045129 F1000 Recommendation
56. Robinson BS Moberg KH: Cell-cell junctions: α-catenin and E-cadherin help fence in Yap1. Curr Biol. 2011;21(21):R890-2. 22075429 10.1016/j.cub.2011.09.019
57. Eckert F Wolff H Ring J: Das atypische Fibroxanthom. Hautarzt. 1990;41(1):39-42. 2179170
58. Heallen T Zhang M Wang J: Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458-61. 21512031 10.1126/science.1199010 3133743 F1000 Recommendation
59. Imajo M Miyatake K Iimura A: A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J. 2012;31(5):1109-22. 22234184 10.1038/emboj.2011.487 3297994 F1000 Recommendation
60. Rosenbluh J Nijhawan D Cox AG: β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151(7):1457-73. 23245941 10.1016/j.cell.2012.11.026 3530160 F1000 Recommendation
61. Gumbiner BM Kim N: The Hippo-YAP signaling pathway and contact inhibition of growth. J Cell Sci. 2014;127(Pt 4):709-17. 24532814 10.1242/jcs.140103 3924201
62. Yue T Tian A Jiang J: The cell adhesion molecule echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway. Dev Cell. 2012;22(2):255-67. 22280890 10.1016/j.devcel.2011.12.011 3288783 F1000 Recommendation
63. Wei SY Escudero LM Yu F: Echinoid is a component of adherens junctions that cooperates with DE-Cadherin to mediate cell adhesion. Dev Cell. 2005;8(4):493-504. 15809032 10.1016/j.devcel.2005.03.015 F1000 Recommendation
64. Bossuyt W Chen CL Chen Q: An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene. 2014;33(10):1218-28. 23563179 10.1038/onc.2013.82
65. Herr KJ Tsang YN Ong JW: Loss of α-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep. 2014;4:6835. 25355493 10.1038/srep06835 4213774
66. Rauskolb C Sun S Sun G: Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell. 2014;158(1):143-56. 24995985 10.1016/j.cell.2014.05.035 4082802 F1000 Recommendation
67. Yang CC Graves HK Moya IM: Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules. Proc Natl Acad Sci U S A. 2015;112(6):1785-90. 25624491 10.1073/pnas.1420850112 4330745 F1000 Recommendation
68. Cappello S Gray MJ Badouel C: Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat Genet. 2013;45(11):1300-8. 24056717 10.1038/ng.2765 F1000 Recommendation
69. Van Hateren NJ Das RM Hautbergue GM: FatJ acts via the Hippo mediator Yap1 to restrict the size of neural progenitor cell pools. Development. 2011;138(10):1893-902. 21521736 10.1242/dev.064204 3082296 F1000 Recommendation
70. Fan R Kim NG Gumbiner BM: Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc Natl Acad Sci U S A. 2013;110(7):2569-74. 23359693 10.1073/pnas.1216462110 3574943 F1000 Recommendation
71. Reddy BV Irvine KD: Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell. 2013;24(5):459-71. 23484853 10.1016/j.devcel.2013.01.020 3624988 F1000 Recommendation
72. White MD Plachta N: How adhesion forms the early mammalian embryo. Curr Top Dev Biol. 2015;112:1-17. 25733136 10.1016/bs.ctdb.2014.11.022
73. Chan SW Lim CJ Chong YF: Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem. 2011;286(9):7018-26. 21224387 10.1074/jbc.C110.212621 3044958 F1000 Recommendation
74. Wang W Huang J Chen J: Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem. 2011;286(6):4364-70. 21187284 10.1074/jbc.C110.205401 3039387 F1000 Recommendation
75. Zhao B Li L Lu Q: Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25(1):51-63. 21205866 10.1101/gad.2000111 3012936 F1000 Recommendation
76. Varelas X Samavarchi-Tehrani P Narimatsu M: The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Dev Cell. 2010;19(6):831-44. 21145499 10.1016/j.devcel.2010.11.012 F1000 Recommendation
77. Yi C Shen Z Stemmer-Rachamimov A: The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal. 2013;6(291):ra77. 24003254 10.1126/scisignal.2004060 4175526 F1000 Recommendation
78. Hirate Y Hirahara S Inoue K: Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr Biol. 2013;23(13):1181-94. 23791731 10.1016/j.cub.2013.05.014 3742369 F1000 Recommendation
79. Yin F Yu J Zheng Y: Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell. 2013;154(6):1342-55. 24012335 10.1016/j.cell.2013.08.025 3835333 F1000 Recommendation